文献速递前列腺癌

退伍军人健康系统中低危前列腺癌保守治疗的应用差异

Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.
PubMed 文献 · Eur Urol · 2020-02-22

多因素分析显示,指南提及的患者因素(如年龄、活检针数)、其他患者因素(如婚姻状况、PSA)及非患者因素(如地理区域、病例量、年份)均与保守治疗使用相关。结论认为即便在整合医疗系统内,保守治疗应用仍存在显著异质性。

要点

  • 低危前列腺癌保守治疗使用率从2010年51%升至2016年76%。
  • 各机构保守治疗使用率差异显著,范围35-100%。
  • 指南内因素(年龄、活检针数)对预测保守治疗影响最大。

核心结论

  • 在退伍军人健康系统内,低危前列腺癌保守治疗使用率随时间显著增加,但机构间仍存在显著异质性。
  • 指南提及的因素及其他未提及因素均与保守治疗使用相关,其中指南提及因素预测作用最大。

主要发现

  • 保守治疗使用率从51%增加至76%(p<0.001)。
  • 机构间保守治疗使用率差异范围为35-100%。
  • 多因素分析显示,指南内患者因素(如年龄、活检针数)、其他患者因素(如婚姻状况、PSA)及非患者因素(如地理区域、病例量、年份)均与保守治疗使用相关。

关键数值与推荐

  • 当前指南推荐保守治疗为大多数低危前列腺癌的首选方案,可能例外包括年龄<55岁、非裔美国人及高体积分级组1。

临床怎么用

  • 临床中对低危前列腺癌患者应考虑保守治疗为首选,但需注意机构间实践差异。
  • 决策时应综合评估指南提及因素及其他患者和非患者因素,以减少不必要差异。

局限性

  • 研究未明确报告局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current guidelines recommend conservative management as the preferred option for most low-risk prostate cancer cases, with certain possible exceptions (age <55yr, African Americans, and high-volume grade group 1). Although previous studies have documented substantial heterogeneity in the uptake of conservative management, less is known about the underlying reason for this variation and whether it is due to guideline-concordant factors (age, race, and biopsy cancer volume). We explored variation in the use of conservative management for low-risk prostate cancer among 20 597 men diagnosed in the US Veterans Affairs health care system from 2010 to 2016. Conservative management increased substantially over this time from 51% to 76% (p< 0.001). However, there was substantial variation by facility (35-100%). Multivariable analysis revealed that patient factors included in the guidelines (e.g., age and biopsy cores), other patient factors (eg, marital status and PSA) and non-patient factors (eg, geographic region, case volume, year) were associated with conservative management use. In conclusion, even within an integrated health care system, there remains significant heterogeneity in the uptake of conservative management for low-risk prostate cancer. Both guideline-concordant factors and other factors not discussed in the guidelines were associated with conservative management use. PATIENT SUMMARY: In the US Veterans Affairs health care system the vast majority of men with low-risk prostate cancer were managed conservatively by 2016, although there was significant variation by facility. Patient factors specifically mentioned in guidelines had the greatest impact on prediction of conservative management.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Loeb S, Byrne NK, Wang B, et al. Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System. Eur Urol. 2020. PMID: 32098730. doi:10.1016/j.eururo.2020.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。